221 related articles for article (PubMed ID: 25286028)
41. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
42. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
[TBL] [Abstract][Full Text] [Related]
43. Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma.
Rodrigues MFSD; Xavier FCA; Andrade NP; Lopes C; Miguita Luiz L; Sedassari BT; Ibarra AMC; López RVM; Kliemann Schmerling C; Moyses RA; Tajara da Silva EE; Nunes FD
Head Neck; 2018 Aug; 40(8):1759-1773. PubMed ID: 29607565
[TBL] [Abstract][Full Text] [Related]
44. Silencing Bmi1 expression suppresses cancer stemness and enhances chemosensitivity in endometrial cancer cells.
Kim M; Lee S; Park WH; Suh DH; Kim K; Kim YB; No JH
Biomed Pharmacother; 2018 Dec; 108():584-589. PubMed ID: 30243092
[TBL] [Abstract][Full Text] [Related]
45. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.
Shiogama S; Yoshiba S; Soga D; Motohashi H; Shintani S
Anticancer Res; 2013 Oct; 33(10):4309-17. PubMed ID: 24122997
[TBL] [Abstract][Full Text] [Related]
46. R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling.
Zhang L; Song Y; Ling Z; Li Y; Ren X; Yang J; Wang Z; Xia J; Zhang W; Cheng B
EBioMedicine; 2019 Jun; 44():275-288. PubMed ID: 31097406
[TBL] [Abstract][Full Text] [Related]
47. Expression of BMI1 and ZEB1 in epithelial-mesenchymal transition of tongue squamous cell carcinoma.
Kurihara K; Isobe T; Yamamoto G; Tanaka Y; Katakura A; Tachikawa T
Oncol Rep; 2015 Aug; 34(2):771-8. PubMed ID: 26043676
[TBL] [Abstract][Full Text] [Related]
48. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
[TBL] [Abstract][Full Text] [Related]
49. Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.
Chen SJ; Chen YT; Zeng LJ; Zhang QB; Lian GD; Li JJ; Yang KG; Huang CM; Li YQ; Chu ZH; Huang KH
Tumour Biol; 2016 Aug; 37(8):11299-309. PubMed ID: 26951514
[TBL] [Abstract][Full Text] [Related]
50. PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells.
Gan YH; Zhang S
Oral Oncol; 2009 Oct; 45(10):e150-4. PubMed ID: 19574087
[TBL] [Abstract][Full Text] [Related]
51. Disulfiram/Copper Suppresses Cancer Stem Cell Activity in Differentiated Thyroid Cancer Cells by Inhibiting BMI1 Expression.
Ni YL; Chien PJ; Hsieh HC; Shen HT; Lee HT; Chen SM; Chang WW
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362068
[TBL] [Abstract][Full Text] [Related]
52. BMI1 activates WNT signaling in colon cancer by negatively regulating the WNT antagonist IDAX.
Yu F; Zhou C; Zeng H; Liu Y; Li S
Biochem Biophys Res Commun; 2018 Feb; 496(2):468-474. PubMed ID: 29337063
[TBL] [Abstract][Full Text] [Related]
53. Effect of shRNA-Mediated Gene Silencing of Bmi-1 Expression on Chemosensitivity of CD44+ Nasopharyngeal Carcinoma Cancer Stem-Like Cells.
Xu XH; Liu Y; Li DJ; Hu J; Su J; Huang Q; Lu MQ; Yi F; Bao D; Fu YZ
Technol Cancer Res Treat; 2016 Oct; 15(5):NP27-39. PubMed ID: 26294655
[TBL] [Abstract][Full Text] [Related]
54. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
[TBL] [Abstract][Full Text] [Related]
55. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
Gergely JE; Dorsey AE; Dimri GP; Dimri M
Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
[TBL] [Abstract][Full Text] [Related]
56. Polycomb (PcG) proteins, BMI1 and SUZ12, regulate arsenic-induced cell transformation.
Kim HG; Kim DJ; Li S; Lee KY; Li X; Bode AM; Dong Z
J Biol Chem; 2012 Sep; 287(38):31920-8. PubMed ID: 22843710
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma.
Qiu M; Liang Z; Chen L; Tan G; Wang K; Liu L; Liu J; Chen H
Urol Oncol; 2015 Jul; 33(7):332.e9-18. PubMed ID: 25953723
[TBL] [Abstract][Full Text] [Related]
58. 5-Azacitidine and Trichostatin A induce DNA damage and apoptotic responses in tongue squamous cell carcinoma: An in vitro study.
Hodjat M; Jourshari PB; Amirinia F; Asadi N
Arch Oral Biol; 2022 Jan; 133():105296. PubMed ID: 34735927
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma.
Bartucci M; Hussein MS; Huselid E; Flaherty K; Patrizii M; Laddha SV; Kui C; Bigos RA; Gilleran JA; El Ansary MMS; Awad MAM; Kimball SD; Augeri DJ; Sabaawy HE
Target Oncol; 2017 Aug; 12(4):449-462. PubMed ID: 28589491
[TBL] [Abstract][Full Text] [Related]
60. miR-300 mediates Bmi1 function and regulates differentiation in primitive cardiac progenitors.
Cruz FM; Tomé M; Bernal JA; Bernad A
Cell Death Dis; 2015 Oct; 6(10):e1953. PubMed ID: 26512961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
